Item 5.03. Amendments to Articles of Incorporation or Bylaws

On June 2, 2026, we filed with the Secretary of State of the State of Nevada a Certificate of Amendment to amend our corporate name from Adia Nutrition, Inc. to Adia Med, Inc. A copy of the Certificate of Amendment of is attached as Exhibit 3.1 hereto and incorporated by reference.

In connection with our name change, our board of directors also filed a Certificate of Amendment for the Company's Amended and Restated Articles of Incorporation to change our corporate name within our Articles of Incorporation to reflect the corporate name Adia Med, Inc., also effective on June 2, 2026. No other changes were made to our articles of incorporation or by-laws. A copy of the Amended and Restated Articles of Incorporation reflecting this amendment is attached as Exhibit 3.2 hereto and incorporated by reference.

Subsequent to the aforementioned amendments, the Company submitted all required documentation to FINRA and its transfer agent, and received final approval from FINRA regarding the name change on July 10, 2026. Due to the coincidental timing of the name change and the end of completion of the review of our quarterly financials, the Company elected to file this Form 8-K after the successful filing of its quarterly report for the three and six months ended June 30, 2026, in order to avoid any potential impacts to the timely filing of its Form 10-Q due to changes necessitated in the Edgar system. All future reports will be filed under our new name "Adia Med, Inc."

Our common stock will continue to trade on the OTC Markets Venture Markets under the ticker symbol "ADIA". Outstanding stock certificates for shares of the Company are not affected by the name change; they continue to be valid and need not be exchanged.